Table 2.

Summary of Results From Baseline to 6 Weeks in the Milnacipran and Placebo Groups

Measure	Milnacipran	Placebo
Visual Analog Scale	No change	No change
Fatigue Severity Scale	No change	No change
Brief Assessment of Cognition	Verbal memory improvement	Verbal memory improvement
MATRICS Consensus Cognitive Battery	Attention-vigilance improvement	Attention-vigilance improvement
Clinical Global Impressions–Severity of Illness	No change	No change
Clinical Global Impressions–Improvement	No change	Worsening
Fibromyalgia Impact Questionnaire	No change	No change
Patients Clinical Global Impression of Change	Transient improvement	No change
Beck Depression Inventory	Transient improvement	No change
Health Assessment Questionnaire	Transient improvement	No change